Humana 2029 increased by 77.8% to $16.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 46.7%, from $30.00M to $16.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests a higher concentration of intangible assets reaching their amortization phase in this period.
The projected amortization expense for finite-lived intangible assets specifically for the fiscal year 2029. This reflec...
Commonly reported in the notes to financial statements for firms with historical acquisition activity.
other_finite_lived_intangible_assets_amortization_expens_a9462e| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $41.00M | $44.00M | $33.00M | $33.00M | $33.00M | $30.00M | $30.00M | $9.00M | $16.00M |
| QoQ Change | — | +7.3% | -25.0% | +0.0% | +0.0% | -9.1% | +0.0% | -70.0% | +77.8% |
| YoY Change | — | — | -19.5% | -25.0% | — | -9.1% | -9.1% | -72.7% | -46.7% |